{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:43:00Z","timestamp":1789576980760,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,26]],"date-time":"2020-01-26T00:00:00Z","timestamp":1579996800000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007494","name":"Fondation Plan Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015721","name":"Caisse nationale de solidarit\u00e9 pour l'autonomie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001115","name":"Cancer Nurses Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001115","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jamda.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:43:01Z","timestamp":1538599381000},"page":"188-194.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploiting Drug-Apolipoprotein E Gene Interactions in Hypertension to Preserve Cognitive Function: The 3-City Cohort Study"],"prefix":"10.1016","volume":"20","author":[{"given":"Phillip J.","family":"Tully","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Helmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tzourio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","article-title":"Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases","volume":"342","author":"Saunders","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/mp.2010.137","article-title":"APOE E4 status predicts age-related cognitive decline in the ninth decade: Longitudinal follow-up of the Lothian Birth Cohort 1921","volume":"17","author":"Schiepers","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jamda.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-140630","article-title":"Interactive effect of APOE genotype and blood pressure on cognitive decline: The PATH through life study","volume":"44","author":"Andrews","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1212\/WNL.0000000000001379","article-title":"Effects of vascular risk factors and APOE epsilon4 on white matter integrity and cognitive decline","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: Analysis of data from the ONTARGET and TRANSCEND studies","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/aje\/153.3.225","article-title":"Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication?","volume":"153","author":"Guo","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.61.5.655","article-title":"Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD","volume":"61","author":"Qiu","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1161\/hs1201.100392","article-title":"Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: The Honolulu-Asia Aging Study","volume":"32","author":"Peila","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"787805","DOI":"10.1155\/2015\/787805","article-title":"Calcium channel blockers, progression to dementia, and effects on amyloid beta peptide production","volume":"2015","author":"Lovell","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jamda.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-130716","article-title":"Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele","volume":"37","author":"Qiu","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jagp.2012.08.017","article-title":"Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele","volume":"22","author":"Qiu","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jso.21838","article-title":"Genomic signatures of cancer: Basis for individualized risk assessment, selective staging and therapy","volume":"103","author":"Baehner","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jamda.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.2017.11469","article-title":"Effect of genotype-guided warfarin dosing on\u00a0clinical events and anticoagulation control among patients undergoing hip or\u00a0knee arthroplasty: The gift randomized clinical trial","volume":"318","author":"Gage","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa1311388","article-title":"A\u00a0randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon","volume":"369","author":"Verhoef","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: From cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jamda.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","article-title":"Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease","volume":"49","author":"Kang","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11886-014-0559-3","article-title":"Statins and cognitive function: An updated review","volume":"17","author":"Chatterjee","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jamda.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer's disease: An analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: A scientific statement from the American Heart Association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jamda.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-016-0200-3","article-title":"A\u00a0call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline","volume":"8","author":"Dacks","year":"2016","journal-title":"Alzheimer Res Ther"},{"key":"10.1016\/j.jamda.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000072920","article-title":"Vascular factors and risk of dementia: Design of the Three-City Study and baseline characteristics of the study population","volume":"22","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jamda.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmjopen-2013-002881","article-title":"Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia","volume":"3","author":"Gao","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jamda.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jamda.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0035-3787(04)71143-1","article-title":"Normative data for the MMSE, the Benton visual retention test, the Isaacs's set test, the digit symbol substitution test and the Zazzo's cancellation task in subjects over the age 70: Results from the PAQUID Study","volume":"160","author":"Lechevallier-Michel","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jamda.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1037\/h0093567","article-title":"An analysis of certain psychological tests used for the evaluation of brain injury","volume":"60","author":"Armitage","year":"1946","journal-title":"Psychol Monogr"},{"key":"10.1016\/j.jamda.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1076\/1380-3395(200008)22:4;1-0;FT518","article-title":"Trail making test, part B as a measure of executive control: Validation using a set-switching paradigm","volume":"22","author":"Arbuthnott","year":"2000","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"key":"10.1016\/j.jamda.2018.08.002_bib31","series-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","year":"2000"},{"key":"10.1016\/j.jamda.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/aje\/kwv212","article-title":"Jump, hop, or skip: Modeling practice effects in studies of determinants of cognitive change in older adults","volume":"183","author":"Vivot","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.clpt.6100483","article-title":"The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women","volume":"84","author":"Yasar","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jamda.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bcp.12511","article-title":"Angiotensin receptor blockers and risk of dementia: Cohort study in UK Clinical Practice Research Datalink","volume":"79","author":"Goh","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2016.05.003","article-title":"Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis","volume":"624","author":"Zhuang","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jamda.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"2422.e3","DOI":"10.1016\/j.neurobiolaging.2014.04.022","article-title":"Influence of Alzheimer's disease genes on cognitive decline: The Guangzhou Biobank Cohort Study","volume":"35","author":"Gui","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2014.13111543","article-title":"Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age","volume":"171","author":"Zannas","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2012.12.009","article-title":"Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus","volume":"43","author":"Bild","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jamda.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2011.09.016","article-title":"Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats","volume":"1421","author":"Yamada","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jamda.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid \u03b2-peptide (A\u03b2); retards A\u03b2 aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jamda.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1470320315583582","article-title":"Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions","volume":"16","author":"Kalra","year":"2015","journal-title":"J\u00a0Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.jamda.2018.08.002_bib44","first-page":"1","article-title":"Effect of SSRI and calcium channel blockers on depression symptoms and cognitive function in elderly persons treated for hypertension: Three City cohort study","volume":"21","author":"Tully","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jamda.2017.11.017","article-title":"Antihypertensive medication regimen intensity and incident dementia in an older population","volume":"19","author":"Tan","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"864.e17","DOI":"10.1016\/j.jamda.2016.06.021","article-title":"Subclinical mood and cognition impairments and blood pressure control in a large cohort of elderly hypertensives","volume":"17","author":"Piotrowicz","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2018.08.002_bib47","first-page":"247","article-title":"Mixed dyslipidemias in primary care patients in France","volume":"8","author":"Laforest","year":"2012","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.jamda.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"193.e7","DOI":"10.1016\/j.jamda.2016.11.011","article-title":"A\u00a0U-shaped association between blood pressure and cognitive impairment in Chinese elderly","volume":"18","author":"Lv","year":"2017","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/mp.2015.62","article-title":"Association of Alzheimer's related genotypes with cognitive decline in multiple domains: Results from the Three-City Dijon study","volume":"20","author":"Vivot","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jamda.2018.08.002_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1515\/cclm.2002.197","article-title":"TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E","volume":"40","author":"Koch","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jamda.2018.08.002_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.hjh.0000198028.84353.86","article-title":"Prevalence, awareness, treatment, and control of hypertension in the elderly: The Three City study","volume":"24","author":"Brindel","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2018.08.002_bib52","series-title":"Guidelines for ATC classification and DDD assignment","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.jamda.2018.08.002_bib53","doi-asserted-by":"crossref","first-page":"h2335","DOI":"10.1136\/bmj.h2335","article-title":"Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: Population based cohort study","volume":"350","author":"Alp\u00e9rovitch","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.jamda.2018.08.002_bib54","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jamda.2018.08.002_bib55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","article-title":"Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function","volume":"16","author":"Froissart","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jamda.2018.08.002_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: A self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"App Psychol Meas"},{"key":"10.1016\/j.jamda.2018.08.002_bib57","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/STROKEAHA.115.012321","article-title":"Antihypertensive drug use, blood pressure variability, and incident stroke risk in older adults: Three-City cohort study","volume":"47","author":"Tully","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2018.08.002_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: A statistical approach to defining meaningful change in psychotherapy research","volume":"59","author":"Jacobson","year":"1991","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.jamda.2018.08.002_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/aje\/153.3.225","article-title":"Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication?","volume":"153","author":"Guo","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2018.08.002_bib60","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.61.5.655","article-title":"Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD","volume":"61","author":"Qiu","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.08.002_bib61","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1161\/hs1201.100392","article-title":"Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: The Honolulu-Asia aging study","volume":"32","author":"Peila","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2018.08.002_bib62","doi-asserted-by":"crossref","first-page":"787805","DOI":"10.1155\/2015\/787805","article-title":"Calcium channel blockers, progression to dementia, and effects on amyloid beta peptide production","volume":"2015","author":"Lovell","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jamda.2018.08.002_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-130716","article-title":"Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele","volume":"37","author":"Qiu","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.08.002_bib64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jagp.2012.08.017","article-title":"Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele","volume":"22","author":"Qiu","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.08.002_bib65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/gepi.20637","article-title":"To stratify or not to stratify: Power considerations for population-based genome-wide association studies of quantitative traits","volume":"35","author":"Behrens","year":"2011","journal-title":"Genet Epidemiol"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861018304444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861018304444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:18:43Z","timestamp":1761506323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861018304444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1525861018304444"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2018.08.002","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting Drug-Apolipoprotein E Gene Interactions in Hypertension to Preserve Cognitive Function: The 3-City Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}